United States Saxagliptin Market Report 2017

July 2017 | 100 pages | ID: U2141372836EN
QYResearch

Abstracts

In this report, the United States Saxagliptin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Saxagliptin in these regions, from 2012 to 2022 (forecast).

United States Saxagliptin market competition by top manufacturers/players, with Saxagliptin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bristol-Myers Squibb Company
• AstraZeneca

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 2.5mg
• 5mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Saxagliptin for each application, including

• Type 2 Diabetes
• Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Saxagliptin Market Report 2017

1 SAXAGLIPTIN OVERVIEW

1.1 Product Overview and Scope of Saxagliptin
1.2 Classification of Saxagliptin by Product Category
  1.2.1 United States Saxagliptin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Saxagliptin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 2.5mg
  1.2.4 5mg
1.3 United States Saxagliptin Market by Application/End Users
  1.3.1 United States Saxagliptin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Type 2 Diabetes
  1.3.2 Application
1.4 United States Saxagliptin Market by Region
  1.4.1 United States Saxagliptin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Saxagliptin Status and Prospect (2012-2022)
  1.4.3 Southwest Saxagliptin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Saxagliptin Status and Prospect (2012-2022)
  1.4.5 New England Saxagliptin Status and Prospect (2012-2022)
  1.4.6 The South Saxagliptin Status and Prospect (2012-2022)
  1.4.7 The Midwest Saxagliptin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Saxagliptin (2012-2022)
  1.5.1 United States Saxagliptin Sales and Growth Rate (2012-2022)
  1.5.2 United States Saxagliptin Revenue and Growth Rate (2012-2022)

2 UNITED STATES SAXAGLIPTIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Saxagliptin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Saxagliptin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Saxagliptin Average Price by Players/Suppliers (2012-2017)
2.4 United States Saxagliptin Market Competitive Situation and Trends
  2.4.1 United States Saxagliptin Market Concentration Rate
  2.4.2 United States Saxagliptin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Saxagliptin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SAXAGLIPTIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Saxagliptin Sales and Market Share by Region (2012-2017)
3.2 United States Saxagliptin Revenue and Market Share by Region (2012-2017)
3.3 United States Saxagliptin Price by Region (2012-2017)

4 UNITED STATES SAXAGLIPTIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Saxagliptin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Saxagliptin Revenue and Market Share by Type (2012-2017)
4.3 United States Saxagliptin Price by Type (2012-2017)
4.4 United States Saxagliptin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SAXAGLIPTIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Saxagliptin Sales and Market Share by Application (2012-2017)
5.2 United States Saxagliptin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SAXAGLIPTIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bristol-Myers Squibb Company
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Saxagliptin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bristol-Myers Squibb Company Saxagliptin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Saxagliptin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Saxagliptin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview

7 SAXAGLIPTIN MANUFACTURING COST ANALYSIS

7.1 Saxagliptin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Saxagliptin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Saxagliptin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Saxagliptin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SAXAGLIPTIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Saxagliptin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Saxagliptin Sales Volume Forecast by Type (2017-2022)
11.3 United States Saxagliptin Sales Volume Forecast by Application (2017-2022)
11.4 United States Saxagliptin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Saxagliptin
Figure United States Saxagliptin Market Size (K Units) by Type (2012-2022)
Figure United States Saxagliptin Sales Volume Market Share by Type (Product Category) in 2016
Figure 2.5mg Product Picture
Figure 5mg Product Picture
Figure United States Saxagliptin Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Saxagliptin by Application in 2016
Figure Type 2 Diabetes Examples
Table Key Downstream Customer in Type 2 Diabetes
Table Key Downstream Customer in Application
Figure United States Saxagliptin Market Size (Million USD) by Region (2012-2022)
Figure The West Saxagliptin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Saxagliptin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Saxagliptin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Saxagliptin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Saxagliptin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Saxagliptin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Saxagliptin Sales (K Units) and Growth Rate (2012-2022)
Figure United States Saxagliptin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Saxagliptin Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Saxagliptin Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Saxagliptin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Saxagliptin Sales Share by Players/Suppliers
Figure 2017 United States Saxagliptin Sales Share by Players/Suppliers
Figure United States Saxagliptin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Saxagliptin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Saxagliptin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Saxagliptin Revenue Share by Players/Suppliers
Figure 2017 United States Saxagliptin Revenue Share by Players/Suppliers
Table United States Market Saxagliptin Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Saxagliptin Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Saxagliptin Market Share of Top 3 Players/Suppliers
Figure United States Saxagliptin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Saxagliptin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Saxagliptin Product Category
Table United States Saxagliptin Sales (K Units) by Region (2012-2017)
Table United States Saxagliptin Sales Share by Region (2012-2017)
Figure United States Saxagliptin Sales Share by Region (2012-2017)
Figure United States Saxagliptin Sales Market Share by Region in 2016
Table United States Saxagliptin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Saxagliptin Revenue Share by Region (2012-2017)
Figure United States Saxagliptin Revenue Market Share by Region (2012-2017)
Figure United States Saxagliptin Revenue Market Share by Region in 2016
Table United States Saxagliptin Price (USD/Unit) by Region (2012-2017)
Table United States Saxagliptin Sales (K Units) by Type (2012-2017)
Table United States Saxagliptin Sales Share by Type (2012-2017)
Figure United States Saxagliptin Sales Share by Type (2012-2017)
Figure United States Saxagliptin Sales Market Share by Type in 2016
Table United States Saxagliptin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Saxagliptin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Saxagliptin by Type (2012-2017)
Figure Revenue Market Share of Saxagliptin by Type in 2016
Table United States Saxagliptin Price (USD/Unit) by Types (2012-2017)
Figure United States Saxagliptin Sales Growth Rate by Type (2012-2017)
Table United States Saxagliptin Sales (K Units) by Application (2012-2017)
Table United States Saxagliptin Sales Market Share by Application (2012-2017)
Figure United States Saxagliptin Sales Market Share by Application (2012-2017)
Figure United States Saxagliptin Sales Market Share by Application in 2016
Table United States Saxagliptin Sales Growth Rate by Application (2012-2017)
Figure United States Saxagliptin Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Saxagliptin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Saxagliptin Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Saxagliptin Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Saxagliptin Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Saxagliptin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Saxagliptin Sales Growth Rate (2012-2017)
Figure AstraZeneca Saxagliptin Sales Market Share in United States (2012-2017)
Figure AstraZeneca Saxagliptin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Saxagliptin
Figure Manufacturing Process Analysis of Saxagliptin
Figure Saxagliptin Industrial Chain Analysis
Table Raw Materials Sources of Saxagliptin Major Players/Suppliers in 2016
Table Major Buyers of Saxagliptin
Table Distributors/Traders List
Figure United States Saxagliptin Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Saxagliptin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Saxagliptin Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Saxagliptin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Saxagliptin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Saxagliptin Sales Volume (K Units) Forecast by Type in 2022
Table United States Saxagliptin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Saxagliptin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Saxagliptin Sales Volume (K Units) Forecast by Application in 2022
Table United States Saxagliptin Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Saxagliptin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Saxagliptin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Saxagliptin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources